Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rhinovirus Challenge in Bronchiectasis
NCT06931002Recruiting
- Sponsor
- Imperial College London
- Start
- Jul 2024
- Primary completion
- Apr 2027
- Countries
- 1
01
Overview
Open-label, single-arm trial, sponsored by Imperial College London. Primary endpoint: Lower respiratory tract symptom scores at 42 days. Started Jul 2024; status: recruiting.
Beyond the preview
Go deeper on NCT06931002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06931002.